|
|
|
Insider
Information: |
Ji Henry |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
6,571,078 |
|
Indirect Shares
|
3,458,951 |
|
|
Direct
Value |
$70,804 |
|
|
Indirect Value
|
$5,011,703 |
|
|
Total
Shares |
10,030,029 |
|
|
Total
Value |
$5,082,506 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
Percentage
Gain/Loss : |
-85.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sorrento Therapeutics Inc |
SRNE |
See Remarks, Director |
2023-03-17 |
6,265,805 |
2023-03-17 |
2,331,693 |
Premium* |
|
ImmunityBio, Inc |
IBRX |
Director |
|
0 |
2015-07-27 |
776,535 |
Premium* |
|
Scilex Holding Co |
SCLX |
|
2024-05-17 |
305,273 |
2024-05-17 |
350,723 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRNE |
Sorrento Therapeutics Inc |
Chief Sci. Officer & Secretary |
|
2009-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,785,375 |
|
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2015-07-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
776,535 |
|
- |
|
SCLX |
Scilex Holding Co |
Executive ChairpersonOfficer |
|
2023-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
300,723 |
|
- |
|
SCLX |
Scilex Holding Co |
Executive ChairpersonOfficer |
|
2023-09-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
305,273 |
|
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Sci. Officer & Secretary |
|
2009-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
50,968,657 |
52,754,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
|
2010-04-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000,000 |
43,754,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
|
2010-05-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
38,657,167 |
38,657,167 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
|
2010-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,657,167 |
5,096,865 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
|
2010-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,096,865 |
0 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
|
2010-11-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,096,865 |
43,754,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
|
2012-02-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
450,000 |
43,304,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
|
2012-03-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,000 |
43,154,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
President and CEO |
|
2013-07-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
25,000 |
43,129,032 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
President and CEO |
|
2013-09-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
1,723,162 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
President and CEO |
|
2014-06-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(250,000) |
2,088,162 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
President and CEO |
|
2014-09-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
20,000 |
2,068,162 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
President and CEO |
|
2016-11-08 |
4 |
A |
$0.00 |
$0 |
I/I |
67,931 |
67,931 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2017-09-11 |
4 |
A |
$0.00 |
$0 |
I/I |
67,932 |
135,863 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2018-01-21 |
4 |
B |
$0.00 |
$0 |
D/D |
1,801,801 |
1,841,577 |
2.73 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2022-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500,000 |
4,621,362 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2022-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500,000 |
6,265,805 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
|
2012-05-15 |
4 |
B |
$0.16 |
$1,000,000 |
I/I |
6,250,000 |
6,250,000 |
2.64 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2023-03-17 |
4 |
OE |
$0.80 |
$15,653 |
I/I |
19,500 |
20,000 |
0 |
- |
|
SCLX |
Scilex Holding Co |
Executive Chairperson |
|
2024-05-17 |
4 |
B |
$0.88 |
$43,985 |
I/I |
50,000 |
50,070 |
0.01 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
See Remarks |
|
2018-07-20 |
4 |
OE |
$1.75 |
$10,500 |
D/D |
6,000 |
2,045,807 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|